A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

Multiple Sclerosis Market Growth is Driven by Advanced Treatment Solutions and Rising Patient PopulationsPune, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size & Growth Analysis: ...

Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

A new study has found that the gut microbiome plays a crucial role in the development of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system. The findings may ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Gut microbiome plays a significant role in the onset of multiple sclerosis (MS) -- an autoimmune disease that impacts the ce ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Spasticity in multiple sclerosis was the most common condition cited by the doctors for treatment with medical cannabis, ...